Logan Lutton

Out of the three stages of menopause, perimenopausal women living with HIV experience the worst COVID-19 symptoms, possibly due to increased inflammation.

When taken in combination with an ART regimen, metformin reduced the amount of HIV production and reduced inflammation by hindering production of the molecule that helps HIV multiply.

If approved, neffy would be the first new delivery method in more than 35 years for small children.

Insight into nocturnal hot flash timing could provide clues about heart disease risk in perimenopausal women.

Kristi Funk, M.D., FACS, medical director and co founder of the Pink Lotus Breast Center, describes why there is a lack of awareness surrounding the link between breast cancer and nutrition.

Women with disadvantaged backgrounds may also benefit more than women with a higher socioeconomic status, study results show.

Here's what you missed this week on Managed Healthcare Executive.

HIV treatments using a single pill improve adherence and are cheaper to maintain.

Joseph Shields of TransparencyRx predicts there will be more lawsuits against self-funded employers alleging they’ve mismanaged prescription drug benefits through PBMs.

During an interview, Joseph Shields of TransparencyRx discusses the PBM legislation that is expected to move forward in Congress in the next few months.

Breast cancer patients were also less likely to have a breast reconstruction than patients living elsewhere.

Sebetralstat would be the first oral, on-demand treatment for hereditary angioedema if approved.

Here’s what you missed this week on Managed Healthcare Executive.

Emergent BioSolutions is planning to donate 50,000 doses of the mpox vaccine to countries in Central Africa.

A new survey of Medicaid-eligible New England residents examines healthcare inequities in detail.

This latest grant is part of a larger $500 million CMS program designed to identify and support communities in need.

A recent study predicts a $34 to $145 billion annual cost for semaglutide due to Medicare’s decision to cover semaglutide for overweight patients with cardiovascular disease.

Here’s what you missed this week on Managed Healthcare Executive.

Having a first-degree relative with colorectal cancer increases risk by two to four times.

Manuka honey inhibited the growth of breast cancer tumors by 84% in mice.

Death and infection rates this year caused by the latest clade 1b strain have already surpassed last year's numbers. At this time, it’s unclear if having HIV increases the risk of mpox.

Here’s what you missed this week on Managed Healthcare Executive.

The Rx Save Card is a new, employer-funded, pre-paid pharmacy discount service that allows consumers to pick between PBM prices and prices available through traditional discount cards.

This therapy is a first-in-class treatment for chronic graft-versus-host disease, which develops in roughly 42% of those who receive a stem cell of bone marrow transplant.

In 2016, Medicare expenses for traumatic brain injuries totaled more than $16 billion and car crashes were the third-leading cause of hospitalizations, emergency room visits and deaths.

Although half of all BRCA1 and BRCA2 mutation carriers are men, cancer screening rates lag when compared with women.

This first-in-class treatment targets multiple disease mechanisms such as itch and inflammation associated with this condition.

Enzeevu is biosimilar to Eylea (aflibercept), which was FDA-approved in 2019.

Here’s what you missed this week on Managed Healthcare Executive.

Neffy is the first epinephrine product that does not need to be administered by injection and the first new epinephrine delivery method in 35 years. It will be available at a starting price of $25.